RxDoctor Payments DataLook up a doctor →

Ryan Price, PA

Physician Assistant · Yuma, AZNPI 1013429000

Payments from drug & device makers

$16,664in general payments, 2019–2025

Across 938 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$1K
  • Neurocrine Biosciences, Inc.$1K
  • Eisai Inc.$1K
  • UCB, Inc.$965
  • Biogen$708
  • plus $9K from 50 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)257$3,118
Novartis60$1,146
Neurocrine Biosciences, Inc.47$1,132
Eisai Inc.40$1,013
UCB, Inc.53$965
Biogen36$708
Teva Pharmaceuticals USA, Inc.39$652
Sanofi25$593
Neurelis, Inc.34$570
AstraZeneca21$542
SK Life Science, Inc.29$487
Lilly USA, LLC25$372
Catalyst Pharmaceuticals, Inc.15$365
ANI Pharmaceuticals, Inc.11$326
Mallinckrodt Hospital Products Inc.12$317
Lundbeck LLC18$295
Boston Scientific21$290
Sumitomo Pharma America, Inc.20$268
Acadia Pharmaceuticals Inc14$261
Amneal Pharmaceuticals LLC13$240
Amgen(2 entities)14$227
Pfizer11$220
Argenx US, Inc.10$211
Johnson & Johnson4$190
Grifols USA, LLC6$189
Genentech USA, Inc.10$187
TG Therapeutics, Inc.3$172
EMD Serono, Inc.1$125
Acorda Therapeutics, Inc7$112
Travere Therapeutics, Inc.15$110
CSL Behring5$101
Supernus Pharmaceuticals, Inc.5$94
Biohaven Pharmaceutical Holding Company Ltd.4$79
Upsher-smith Laboratories LLC4$75
Corium, LLC4$73
Kyowa Kirin, Inc.3$73
Greenwich Biosciences, Inc.3$71
Tanabe Pharma America, Inc.4$69
Jazz Pharmaceuticals Inc.3$66
Medtronic4$66
Biohaven Pharmaceuticals, Inc.3$53
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$50
Averitas Pharma Inc.2$49
Merz Pharmaceuticals, LLC2$48
Sunovion Pharmaceuticals Inc.3$42
Harmony Biosciences LLC2$33
Livanova USA, Inc.2$33
Alnylam Pharmaceuticals Inc.2$31
Nevro Corp.2$30
Xeris Pharmaceuticals, Inc.1$23
Abbott1$22
Electromed, Inc.1$18
Otsuka America Pharmaceutical, Inc.1$17
Neuronetics, Inc.1$16
OWP Pharmaceuticals, Inc.1$15
Axsome Therapeutics, Inc.1$14

How this compares

$16,664 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona →

Medicare billing

Part B allowed, 2024
$63,360
Medicare patients
263
Services billed
623

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Yuma

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →